申请人:Watkins William J.
公开号:US20080171724A1
公开(公告)日:2008-07-17
Phosphorus substituted mycophenolate oxime derivatives with anti-cancer, anti-viral, anti-inflammatory anti-tissue/organ transplant rejection properties having use as therapeutics and for other industrial purposes are disclosed. The compositions inhibit tumor growth, viral growth, inflammation, and tissue/organ transplant rejection and/or are useful therapeutically for the treatment or prevention of cancer, viral infection, inflammation and tissue/organ transplant rejection, as well as in assays for the detection of cancer, viral infection, inflammation and tissue/organ transplant rejection.
本发明揭示了磷取代的霉酚酸酯衍生物,具有抗癌、抗病毒、抗炎、抗组织/器官移植排斥等性质,可用作治疗剂和其他工业用途。这些组合物可抑制肿瘤生长、病毒生长、炎症和组织/器官移植排斥,或在治疗或预防癌症、病毒感染、炎症和组织/器官移植排斥方面有用,同时还可用于检测癌症、病毒感染、炎症和组织/器官移植排斥的试验中。